Sangamo

This page shows the latest Sangamo news and features for those working in and with pharma, biotech and healthcare.

Roche's O’Day swaps big pharma for big biotech

with Sangamo to use its zinc finger gene-editing platform for drug discovery, and a $1.2bn deal to acquire Nimbus Therapeutics and its non-alcoholic steatohepatitis (NASH) candidate selonsertib.

Latest news

Sangamo’s first gene-editing trial doesn’t convince investors

Market spooked by inconclusive early results. Sangamo Therapeutics has claimed a first with a trial of its genome-editing technology for rare disease Hunter syndrome, but the data didn’t convince ... Elaprase costs hundreds of thousands of dollars per
Spark sputters on haemophilia A gene therapy safety scare

meeting the factor threshold because of reactions – suggesting that could affect SPK-8011’s competitive profile compared to other haemophilia A gene therapies from the likes of BioMarin Pharma, Pfizer/Sangamo
Sangamo bulks up in cell therapy with TxCell acquisition

Hopes to start cell-based immunotherapy trials next year. Sangamo has agreed a 72m deal to take control of French biotech TxCell, eyeing a regulatory T cell (Treg) platform that it ... Sangamo’s zinc finger nuclease (ZFN) gene-editing technology is
Daily Brief: Brexit reshuffle brings new health minister, Celgene thalassemia success, Wellcome ready to leap into future

Competition in the therapy area is hotting up, however: Bluebird has recently produced compelling data on its beta-thalassemia gene therapy, with Sangamo also pursuing a similar approach.
Sarepta soars on positive Duchenne data

Sarepta’s experimental treatment one of a clutch of DMD gene therapies in clinical testing along with candidates from Sangamo, Bamboo/Pfizer, and Solid Biosciences.

More from news
Approximately 6 fully matching, plus 8 partially matching documents found.

Latest Intelligence

The handover: Pfizer reshapes itself for a new era

It has gene therapy deals with Spark in haemophilia and with Sangamo in ALS.
Deal Watch table for January 2014

320. Sangamo/Biogen Idec . Collaboration and licence. Development of therapies for haemoglobinopathies using zinc finger genome editing.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Eric Rhodes becomes CEO of ERS Genomics

Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Editorial Assistant – Greater Manchester: DOE

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Medical (Scientific) Director: £120, 000 benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Account Director: Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Editorial Manager - MedComms: DOE

Account Manager / Account Director: Competative

Account Executive/ Senior Account Executive: competitive Salary Offfered

Experienced Medical Writers: Competitive Salary and Benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager- Healthcare Advertising: Negotiable

Account Manager / Senior Account Manager: 35, 000-40, 000

Systematic Reviewer - Oxford: Negotiable

Associate Director: £75, 000-90, 000

Healthcare Communications Account Directors x 2: Salary TBC

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager- Healthcare Advertising: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today: Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...